|

Lupus Landmark Study: A Prospective Registry and Biorepository

RECRUITINGSponsored by Lupus Research Alliance
Actively Recruiting
SponsorLupus Research Alliance
Started2023-06-28
Est. completion2035-12
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
Locations16 sites

Summary

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Eligibility

Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria:

* Able to understand and comply with study procedures and voluntarily sign a written informed consent document
* Age 18 years or older at the time of enrollment
* Fulfill criteria for SLE based on one or more of the following classifications systems:

Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.

Exclusion Criteria:

* Not able to obtain consent
* Not able to meet protocol visit requirements
* Pregnant at the time of enrollment

Conditions4

LupusLupus NephritisNeuropsychiatric Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE)

Locations16 sites

University of Alabama at Birmingham
Birmingham, Alabama, 35205
Christina Ndolocmndolo@uabmc.edu
University of Arizona
Tucson, Arizona, 85714
Wallace Rheumatic Studies Center
Beverly Hills, California, 90210
University of Miami
Miami, Florida, 33146
Luis Enrique Arias Mejialxa2090@med.miami.edu
Emory University
Atlanta, Georgia, 30322

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.